BOSCHI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 12.972
AS - Asia 7.916
EU - Europa 5.009
SA - Sud America 1.327
AF - Africa 192
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.463
Nazione #
US - Stati Uniti d'America 12.618
SG - Singapore 2.978
CN - Cina 1.875
IT - Italia 1.387
BR - Brasile 1.041
VN - Vietnam 962
PL - Polonia 669
DE - Germania 650
HK - Hong Kong 624
GB - Regno Unito 487
UA - Ucraina 461
TR - Turchia 315
FI - Finlandia 301
JP - Giappone 242
FR - Francia 240
BD - Bangladesh 224
IN - India 181
SE - Svezia 181
CA - Canada 168
RU - Federazione Russa 166
MX - Messico 137
ID - Indonesia 128
AR - Argentina 103
NL - Olanda 94
ZA - Sudafrica 83
ES - Italia 59
IQ - Iraq 59
BE - Belgio 54
AT - Austria 51
EC - Ecuador 43
UZ - Uzbekistan 42
AU - Australia 41
VE - Venezuela 41
PK - Pakistan 38
CH - Svizzera 37
CO - Colombia 35
IR - Iran 27
CZ - Repubblica Ceca 26
MY - Malesia 26
PH - Filippine 26
LT - Lituania 25
MA - Marocco 23
BG - Bulgaria 21
CL - Cile 21
SA - Arabia Saudita 20
TN - Tunisia 19
DK - Danimarca 15
HU - Ungheria 15
JO - Giordania 15
KE - Kenya 15
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
BO - Bolivia 13
KR - Corea 12
IE - Irlanda 11
PT - Portogallo 11
DZ - Algeria 10
EG - Egitto 10
JM - Giamaica 10
NP - Nepal 10
PY - Paraguay 10
IL - Israele 9
UY - Uruguay 9
KG - Kirghizistan 8
LB - Libano 8
CR - Costa Rica 7
RO - Romania 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
ET - Etiopia 6
KZ - Kazakistan 6
LV - Lettonia 6
BY - Bielorussia 5
HN - Honduras 5
NO - Norvegia 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
GT - Guatemala 4
GY - Guiana 4
AL - Albania 3
BB - Barbados 3
CG - Congo 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
MK - Macedonia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
EU - Europa 2
KH - Cambogia 2
Totale 27.417
Città #
Singapore 1.869
Ashburn 1.493
San Jose 1.116
Woodbridge 846
Fairfield 784
Warsaw 657
Hong Kong 611
Beijing 583
Santa Clara 580
Chandler 572
Houston 556
Ann Arbor 511
Jacksonville 486
Ferrara 332
Wilmington 304
Ho Chi Minh City 292
Seattle 280
Los Angeles 274
New York 241
Tokyo 228
Cambridge 225
Hanoi 213
The Dalles 212
Dallas 205
Nanjing 191
Munich 184
Izmir 179
Addison 159
Lauterbourg 144
Princeton 144
Milan 139
Helsinki 125
Council Bluffs 121
São Paulo 118
Boardman 101
Buffalo 89
Shanghai 88
Dearborn 82
Dong Ket 81
Mexico City 81
Jakarta 78
Orem 73
London 71
Turku 71
San Diego 67
Bologna 63
Montreal 58
Redwood City 57
Da Nang 53
Nuremberg 53
Brooklyn 51
Rome 51
Chennai 49
Bremen 48
Chicago 46
Tianjin 46
Denver 45
Frankfurt am Main 45
Nanchang 44
Brussels 43
Johannesburg 41
Phoenix 41
Shenyang 41
Boston 40
Toronto 40
Atlanta 38
Hefei 37
Stockholm 37
Tashkent 36
Poplar 32
San Francisco 32
Vienna 32
Amsterdam 31
Changsha 31
Haiphong 30
Hebei 30
Moscow 30
Rio de Janeiro 30
Guangzhou 28
Baghdad 24
Falls Church 24
Legnaro 24
L’Aquila 24
Padova 23
Zurich 23
Biên Hòa 22
Jiaxing 22
Kunming 22
Augusta 21
Chengdu 21
Mumbai 21
Ankara 19
Belo Horizonte 19
Charlotte 19
Brasília 18
Dhaka 18
Washington 18
Lahore 17
Monmouth Junction 17
Naples 17
Totale 17.698
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 523
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 391
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 340
Biodistribution of nanostructured lipid carriers: a tomographic study 335
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 326
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 322
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 296
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 289
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 289
A solvent-extraction module for cyclotron production of high-purity technetium-99m 281
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 279
LARAMED: A Laboratory for Radioisotopes of Medical Interest 274
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 272
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 253
YAP-(S)PET small animal scanner: Quantitative results 251
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 243
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 242
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 235
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 234
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 234
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 231
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 226
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 223
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 221
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 219
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 217
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 216
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 213
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 212
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 209
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 208
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 208
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 206
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 206
Extraction techniques of 99mTc from 100Mo Metal Target 200
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 199
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 198
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 198
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 194
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 193
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 192
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 192
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 192
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 189
Development of a β-spectrometer for 99gTc Activity Estimations 188
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 186
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 184
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 184
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 181
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 180
188W/188Re generator system and its therapeutic applicacions 180
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 179
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 177
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 177
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 176
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 174
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 174
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 174
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 172
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 172
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 172
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 170
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 170
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 169
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 169
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 169
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 168
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 166
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 165
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 162
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 161
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 161
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 160
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 160
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 157
Technetium complexes and radiopharmaceuticals with scorpionate ligands 154
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 153
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 153
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 153
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 153
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 151
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 149
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 149
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 147
Radioactive metal complexes comprising a tridentate complexing sequence 147
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 144
Production of 47Sc with natural vanadium targets: results of the PASTA project 144
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 144
Advances in the automation technologies within LARAMED project 143
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 142
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 142
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 141
PASTA Project: Data Analysis 140
Spark plasma sintering in manufacturing and recycling of ZnO targets for medical radioisotopes cyclotron-based production 138
Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2 138
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 138
LABELLING OF SMALL MOLECULES WITH THE 99mTc-NITRIDO CORE (cap.15) 138
Development of a new class of Mn(II) complexes for MRI applications 137
Efficient preparation and stabilization of Re-188-MDP under physiological conditions 136
Cyclotron-based production of innovative medical radionuclides at the INFN-LNL: state of the art and perspective 136
Totale 19.818
Categoria #
all - tutte 119.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.620
Totale 132.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.597 71 118 103 75 66 67 83 92 73 125 245 479
2022/20231.419 163 135 42 173 207 189 95 109 130 25 93 58
2023/20241.046 73 94 99 46 69 125 75 73 33 41 51 267
2024/20254.546 120 111 333 182 462 306 196 268 680 555 893 440
2025/202611.960 1.076 436 930 1.467 1.753 807 1.478 753 1.131 1.302 627 200
Totale 27.856